Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Plaintiffs Propose Schedule for First Trial Over Baby Formula NEC Risk To Begin in Mid-2024 Bellwether schedule would give parties less than two years to prepare the initial baby formula NEC risk bellwether claims for trial. November 16, 2022 Irvin Jackson Add Your Comments Lawyers representing hundreds of families nationwide who are pursuing Similac lawsuits and Enfamil lawsuits, involving allegations that the baby formula manufacturers’ failed to warn about the NEC risk for preterm babies, have proposed a pretrial schedule that would prepare the first “bellwether” cases for trial to begin after March 2024. Each of the claims involve similar claims that premature babies developed necrotizing enterocolitis (NEC) shortly after being fed the cow’s milk-based infant formula while still in the NICU, often resulting in fatal injuries or the need for emergency surgery to remove large sections of the intestines. Families allege that the makers of Similac and Enfamil knew about the baby formula NEC risks for premature infants, yet continued to market and promote their products to hospitals, doctors and parents, without warning about the problems. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the federal court system, a federal baby formula MDL (multidistrict litigation) was established earlier this year for all lawsuits over NEC caused by Similac or Enfamil, centralizing the claims before U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois for coordinated discovery and pretrial proceedings. NEC Lawsuit Bellwether Trial Schedule As part of the management of the litigation, Judge Pallmeyer has established a “bellwether” program, where a group of 12 NEC lawsuits brought against the two infant formula manufacturers will go through case-specific discovery, and be scheduled for a series of early trial dates to help gauge how juries will respond to certain evidence and testimony that will be repeated throughout the litigation. Last month, Judge Pallmeyer identified eight cases that will serve in the initial bellwether pool. In addition, the formula manufacturers have until November 23 to select the last four claims, which will go through case-specific discovery and be eligible for the first bellwether jury trials. On November 10, the Plaintiffs’ Leadership Committee (PLC) submitted a proposed schedule (PDF) for the bellwether trial cases, calling for all case-specific fact discovery to be completed by late April 2023, and the parties completing expert discovery over the remainder of the year. Following any motions for summary judgment or challenges to the admissibility of expert witness testimony, plaintiffs indicate that a pretrial conference be scheduled in March 2024, to discuss scheduling the start of the first jury trials. The proposal claims the schedule is consistent with the Court’s current schedule and goals, which call for depositions to begin in January 2022. The PLC called the schedule aggressive, with the first trial beginning only 21 months after leadership positions were appointed in the litigation. After the completion of fact discovery in the 12 bellwether claims, plaintiffs call for the selection of four cases in May 2023, which will be prepared for trial. “The PLC’s proposed schedule – first circulated to Defendants on June 28, 2022, and submitted to the Court on October 12, 2022… balances efficiency wile also taking into consideration this MDL’s complexity,” Plaintiffs said in a brief (PDF) filed in support of the proposed schedule on November 10. “Ultimately, it contemplates a proposed trial date less than 21 months after this Court appointed the PLC. As such, the PLC’s proposed schedule offers realistic dates that are more likely to hold firm and avoid motion practice to modify the schedule than the schedule proposed by Defendants.” November 2022 NEC Lawsuit Update Once the full list of 12 NEC bellwether lawsuits has been identified later this month, the parties will conduct depositions and case-specific discovery in each claim, examining the circumstances involved with each of the babies use of Similac or Enfamil, and NEC diagnosis. It is then expected that the discovery group will be reduced to a total of four claims for trial, including two selected by Plaintiffs and two selected by Defendants. Within 14 days after the close of fact discovery, the parties will submit their selections for the final trial cases, together with a three-page submission that explains which of the cases they submitted should be tried first, and on what basis. Judge Pallmeyer is then expected to set the NEC lawsuit bellwether trial schedule, determining the order in which the cases will go before juries starting every 12 weeks. While the bellwether process moves forward, NEC baby formula lawyers are continuing to review and file new claims for families nationwide, and the size of the litigation is expected to continue to grow throughout 2023 and 2024. Following the four early trial dates, if the parties fail to negotiate NEC lawsuit settlements for families, it is then likely that Judge Pallmeyer will start remanding dozens of individual claims back to U.S. District Courts nationwide for separate trial dates. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Abbott Laboratories, Enfamil, Infant Death, Infant Formula, Mead Johnson, Necrotizing Enterocolitis, Preterm Birth, Similac Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025 1 Comments Latonya January 24, 2023 As a parent of child whom suffered with NEC God has finally heard our prayers and these Killers will be held accountable for their actions I shed tears as I advocated for my son as I watched my frnds child past .No amount of money can give him all he lost but he will receive a better quality of life .May god have mercy on they evil corrupt souls slaughter ppl for profit. FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: today) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025) Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025) Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (Posted: 2 days ago) Federal indictments against MLB and NBA players reveal how legalized sports betting has blurred the line between competition and addiction, fueling corruption on the field and lawsuits off it. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITSports Betting Addiction Concerns Are Causing More Americans to Oppose Online Gambling (10/31/2025)Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (10/28/2025)Gambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025
GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: today) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)
Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)
Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (Posted: 2 days ago) Federal indictments against MLB and NBA players reveal how legalized sports betting has blurred the line between competition and addiction, fueling corruption on the field and lawsuits off it. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITSports Betting Addiction Concerns Are Causing More Americans to Oppose Online Gambling (10/31/2025)Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (10/28/2025)Gambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)